Olmax 40 Tablet contains Olmesartan Medoxomil 40mg, an angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension. Olmesartan Medoxomil works by selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle, thereby inhibiting vasoconstriction and aldosterone secretion. This results in vasodilation, reduced peripheral resistance, and consequently, lowered blood pressure. Olmax 40 is prescribed to manage high blood pressure, reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure. The medication is typically administered once daily, with or without food, and dosage adjustments should be individualized based on patient response and clinical condition. It is contraindicated in patients with hypersensitivity to Olmesartan or any component of the formulation, and caution is advised in patients with renal impairment, hepatic dysfunction, or volume depletion. Common adverse effects may include dizziness, headache, and fatigue, while serious adverse reactions are rare but may involve hyperkalemia or renal impairment. Regular monitoring of blood pressure, renal function, and electrolyte levels is recommended during therapy. Olmax 40 should be used under medical supervision, and patients should adhere to prescribed dosing and lifestyle modifications to optimize therapeutic outcomes.